Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: RADIOLOGICAL AND CLINICAL EVALUATION OF RENAL EMBOLIZATION USING EVOH IN DIALYSIS PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A PROSPECTIVE LONGITUDINAL OBSERVATIONAL STUDY

View source ↗

Summary

This prospective, longitudinal observational study assesses radiologic and clinical outcomes of renal embolization using Ethylene-vinyl alcohol copolymer (EVOH)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Onyx (ethylene-vinyl alcohol copolymer (EVOH) embolic agent)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Status: RECRUITING